| 000 | 01834 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516033600.0 | ||
| 264 | 0 | _c20111006 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1555-8576 | ||
| 024 | 7 |
_a10.4161/cbt.11.12.15693 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEimer, Sandrine | |
| 245 | 0 | 0 |
_aAutophagy inhibition cooperates with erlotinib to induce glioblastoma cell death. _h[electronic resource] |
| 260 |
_bCancer biology & therapy _cJun 2011 |
||
| 300 |
_a1017-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xmetabolism |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 | _aBcl-2-Like Protein 11 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aErlotinib Hydrochloride |
| 650 | 0 | 4 |
_aGlioblastoma _xpathology |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMitochondria _xmetabolism |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aBelaud-Rotureau, Marc-Antoine | |
| 700 | 1 | _aAiriau, Kelly | |
| 700 | 1 | _aJeanneteau, Marie | |
| 700 | 1 | _aLaharanne, Elodie | |
| 700 | 1 | _aVéron, Nadège | |
| 700 | 1 | _aVital, Anne | |
| 700 | 1 | _aLoiseau, Hugues | |
| 700 | 1 | _aMerlio, Jean-Philippe | |
| 700 | 1 | _aBelloc, Francis | |
| 773 | 0 |
_tCancer biology & therapy _gvol. 11 _gno. 12 _gp. 1017-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.11.12.15693 _zAvailable from publisher's website |
| 999 |
_c20774136 _d20774136 |
||